H. Walker

发表

Impact of karyotype on treatment outcome in acute myeloid leukemia.

D. Grimwade, A. Moorman, A. Burnett, 2004, Annals of hematology.

Granulocytic sarcoma of the small intestine preceding acute myelomonocytic leukemia with abnormal eosinophils and inv(16).

H. Walker, S. J. Russell, F. Giles, 1988, Cancer genetics and cytogenetics.

Establishing the presence of the t( 15; 17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial

D. Grimwade, E. Solomon, A. Goldstone, 1996, British journal of haematology.

Life‐threatening thrombotic and haemorrhagic problems associated with silent myeloproliferative disorders

S. Machin, H. Walker, K. Patterson, 1993, British journal of haematology.

REFINEMENT OF CYTOGENETIC CLASSIFICATION IN AML: DETERMINATION OF PROGNOSTIC SIGNIFICANCE OF RARE RECURRING CHROMOSOMAL ABNORMALITIES AMONGST 5635 YOUNGER ADULTS TREATED IN THE UK MRC TRIALS

R. Hills, D. Grimwade, C. Harrison, 2009 .

Does the P 2 X 1 del variant lacking 17 amino acids in its extracellular domain represent a relevant functional ion channel in platelets ?

L. Campbell, A. Green, D. Niederwieser, 2002 .

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

K Wheatley, D. Grimwade, C. Harrison, 1998, Blood.

Reported cryptic rearrangements of CBFβ-MYH11 in acute myeloid leukaemia are not due to false priming of contaminating DNA

S. Langabeer, R. Gale, D. Linch, 2000, Leukemia.

Molecular characterisation of patients with APL entered into the UK MRC ATRA trial: Relationship of PML breakpoint with additional cytogenetic abnormalities and outcome [Abstract]

S. Langabeer, D. Grimwade, P. Gorman, 1997 .

The importance of diagnostic cytogenetics in older patients with AML: Analysis of 922 patients entered into the MRC AML 11 trial.

D. Grimwade, A. Goldstone, A. Burnett, 1999 .

What happens subsequently in AML when cytogenetic abnormalities persist at bone marrow harvest? Results of the 10th UK MRC AML Trial

D. Grimwade, A. Burnett, K. Wheatley, 1997, Bone Marrow Transplantation.

The significance of host haemopoietic cells detected by cytogenetic analysis of bone marrow from recipients of bone marrow transplants

A. Goldstone, H. Walker, J. Patterson, 1986, British journal of haematology.

Frequency of CBF beta/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials. The MRC Adult Leukaemia Working Party.

S. Langabeer, D. Linch, A. Burnett, 1997, British journal of haematology.

cytometry. IV. CD34 overexpression in acute myelogenous leukemia Leukemia-associated changes identified by quantitative flow

G. Janossy, A. Goldstone, D. Swirsky, 2011 .

An unusual case of nevoid basal cell carcinoma syndrome involving treatment with radiotherapy.

H. Walker, J. Tobias, B. J. Smith, 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

R. Hills, D. Grimwade, C. Harrison, 2010, Blood.

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.

D. Grimwade, C. Harrison, A. Goldstone, 2001, Blood.

Congenital spherocytosis, B19 parvovirus infection and inherited interstitial deletion of the short arm of chromosome 8

J. Delhanty, S. Lucas, H. Walker, 1991, British journal of haematology.

Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21).

G. Janossy, A. Goldstone, D. Swirsky, 1996, Blood.

Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.

P. Freemont, D. Sheer, S. Langabeer, 1997, Blood.

Cytogenetics in acute myeloid leukaemia.

D. Betts, H. Walker, F. J. Smith, 1994, Blood reviews.

A simple, robust, validated and highly predictive index for the determination of risk‐directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

R. Gray, A. Goldstone, A. Burnett, 1999, British journal of haematology.

A chronic myeloproliferative disorder associated with monosomy 7 in the bone marrow cells; normal karyotype in acute transformation

A. Goldstone, D. Linch, H. Walker, 1982, British journal of haematology.

Refinement of cytogenetic classification in acute myeloid leukaemia: Determination of prognostic significance of rarer recurring chromosomal abnormalities amongst 5,876 younger adult patients treated in the UK Medical Research Council trials

R. Hills, D. Grimwade, C. Harrison, 2010 .

Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARα rearrangement in newly diagnosed AML

B. Bain, P. Freemont, S. Langabeer, 1999 .

Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.

B. Bain, P. Freemont, P. Freemont, 1999, British journal of haematology.

Del (9q) AML: clinical and cytological characteristics and prognostic implications

L. Side, C. Harrison, J. Boultwood, 2005, British journal of haematology.

EVI1 expression in acute myeloid leukaemia

B. Bain, S. Langabeer, D. Grimwade, 2001, British journal of haematology.

Impact of diagnostic cytogenetics on outcome in AML: Analysis of 1,613 patients entered into the UK MRC AML 10 trial.

R. Gray, D. Grimwade, C. Harrison, 1996 .

Ring chromosome 6 and i(17q-) in a patient with acute promyelocytic leukemia. Absence of translocation t(15;17).

A. Goldstone, H. Walker, S. J. Russell, 1988, Cancer genetics and cytogenetics.

Heterogeneous Blast Cell Crises in Philadelphia Negative Chronic Granulocytic Leukaemia

G. Janossy, A. Hoffbrand, B. Mcverry, 1981, British journal of haematology.

Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials

D C Linch, K Wheatley, S. Langabeer, 1997, British journal of haematology.

Frequency of CBFβ/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials

S. Langabeer, D. Linch, A. Goldstone, 1997 .

Clonal identification in acute lymphoblastic leukemia.

G. Janossy, B. Mcverry, A. Goldstone, 1979, Blood.

PROLONGED SURVIVAL IN CHRONIC GRANULOCYTIC LEUKAEMIA AFTER BUSULPHAN INDUCED HYPOPLASIA AND KARYOTYPE CONVERSION

H. Walker, M. Bennett, D. Lewis, 1985, British journal of haematology.

Deletions of the derivative chromosome 9 do not account for the poor prognosis associated with Philadelphia-positive acute lymphoblastic leukemia.

L. Campbell, A. Green, D. Niederwieser, 2002, Blood.

A HIDDEN PHILADELPHIA CHROMOSOME

H. Walker, T. Kumaran, J. Yin, 1983, British journal of haematology.

Outcome of acute myeloid leukaemias affecting core binding factor subunits: the UK MRC experience

S. Langabeer, D. Linch, A. Burnett, 1997 .

R. Hills, D. Grimwade, C. Harrison, 2010, Blood.